🇪🇺 Chrft5 in European Union

EMA authorised Chrft5 on 9 October 1998

Marketing authorisation

EMA — authorised 9 October 1998

  • Status: approved

Chrft5 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Chrft5 approved in European Union?

Yes. EMA authorised it on 9 October 1998.

Who is the marketing authorisation holder for Chrft5 in European Union?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.